In contrast, the malignant transformation and accelerated adenoma-carcinoma sequence brought about by the gut-specific expression of oncogenic KRAS result in the establishment of a subpopulation of tumour-initiating cells (estimated as 1 in approx. 7×104 bulk tumour cells). The gene discussed is KRAS; the disease is neoplasm.